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a b s t r a c t
Vitamin B12 (B12) deﬁciency has been linked to developmental disorders, metabolic abnormalities, and
neuropathy; however, the mechanisms involved remain poorly understood. Caenorhabditis elegans
grown under B12-deﬁcient conditions for ﬁve generations develop severe B12 deﬁciency associated with
various phenotypes that include decreased egg-laying capacity (infertility), prolonged life cycle (growth
retardation), and reduced lifespan. These phenotypes resemble the consequences of B12 deﬁciency in
mammals, and can be induced in C. elegans in only 15 days. Thus, C. elegans is a suitable animal model
for studying the biological processes induced by vitamin deﬁciency.
C© 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license.. Introduction
Vitamin B12 (B12), the largest andmost complex vitaminmolecule,
s exclusively synthesized by certain bacteria, and is most abun-
ant in higher order predators in the natural food chain. After B12
s taken up by living cells, it is converted into two coenzyme forms,
′-deoxyadenosylcobalamin (Ado-B12) and methylcobalamin (CH3-
12), which function as the coenzymes for methylmalonyl-CoA mu-
ase (MCM;EC5.4.99.2) [1] andmethionine synthase (MS; EC2.1.1.13)
2], respectively.
Food derived from animal products is the major dietary source
f B12; therefore, strict vegetarians and/or the elderly are at a high
isk of developing B12 deﬁciency [3]. Themajor symptoms of B12 deﬁ-
iency are developmental disorders,megaloblastic anemia,metabolic
bnormalities, and neuropathy [4], although the underlying disease
echanisms are poorly understood [5,6]. Developing animal models
f B12-deﬁciency is essential for investigating the molecular mecha-
isms that aredefective in thismetabolic disorder.However, suchani-
almodels haveprovendifﬁcult to generate because animalsmust be
edwith a B -deﬁcient diet for long periods to achieve B deﬁciency12 12
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ttp://dx.doi.org/10.1016/j.fob.2013.01.008[7]. The lack of robust B12-deﬁcient animal models has limited inves-
tigations to the biochemical mechanisms induced by B12-deﬁciency.
Caenorhabditis elegans offers several advantages for genetic and
biochemical studies, including a short lifespan, a 3-day life cycle, a
completely sequenced genome, <1000 somatic cells, and the abil-
ity to change reproductive rates, life cycle, and locomotive behavior
[8]. In addition, manymolecular and cellular processes are conserved
between nematodes and mammals. Most human disease genes and
pathways are present in the worm [9]. Thus, this animal has been
widely used as a model organism for studying a variety of biologi-
cal processes including apoptosis, cell signaling, cell cycle regulation,
gene regulation, metabolism, and aging [8].
The enzymes responsible for human methylmalonic aciduria, a
disease caused by B12 deﬁciency, have been partially characterized
in C. elegans using RNA interference techniques [10,11]. However,
whether B12 is an absolute requirement for normal growth and phys-
iological function in C. elegans is unknown. If a method for creating
viable B12-deﬁcient worms can be found, C. elegans could serve as a
suitable model organism for studying the effects of B12 deﬁciency.
In this study, we report a novel method for inducing B12 deﬁ-
ciency in C. elegans, describe the effects of B12 deﬁciency on various
biomarkers, and characterize the physiological roles of B12 in this
model organism.an Biochemical Societies. Open access under CC BY-NC-ND license.
Tomohiro Bito et al. / FEBS Open Bio 3 (2013) 112–117 113
Fig. 1. Preparation of B12-deﬁcient C. elegans. Single eggs from C. elegans adults grown
on NGM plate were transferred onto individual plates containing B12-supplemented
M9 seeded with B12-deﬁcient E. coli OP50 (control) and grown for 3 days. The eggs
hatched and developed into adult worms, which then laid eggs. The adult worm was
removed from each plate and individual eggs were transferred individually onto fresh
identical plates. This procedure was repeated at least 10 times. These worms were
used as experimental control worms. To prepare B12-deﬁcient worms, single eggs from
the control worm were transferred onto individual plates containing B12-deﬁcient M9
medium seeded with B12-deﬁcient E. coli and allowed to reach maturity and lay eggs
(F1 generation). F1 worms obtained from these eggs were used to generate F2 worms
following the same procedures. This process was repeated to prepare F5 B12-deﬁcient
worms.2. Materials and methods
2.1. Organisms and growth conditions
The N2 Bristol wild-type C. elegans strain was maintained at 20 ◦C
on nematode growth medium (NGM) plates using the Escherichia coli
OP50 strain as the food source [12]. To induce B12 deﬁciency, worms
were grown on 1.7% (w/v) agar plates containing M9 medium (3 g/L
KH2PO4, 6 g/L Na2HPO4, 0.5 g/L NaCl, 1 g/L NH4Cl, 1 mmol/L MgSO4,
50 μmol/L CaCl2, 2 g/L glucose, 4 mg/L thiamine hydrochloride, and
5 mg/L cholesterol) in 1 L H2O. Plates containing B12-supplemented
(100 μg/L cyanocobalamin) M9-medium each received one egg ob-
tained from worms grown on NGM plates with B12-deﬁcient OP50 E.
coli (described below). Eggs were allowed to hatch and develop into
egg-laying adult worms. The adult worms were then removed from
each plate, eggs were collected, and each egg was transferred onto a
new control plate. After this procedurewas repeated at least 10 times,
the resultant worms were used as experimental controls.
2.2. Preparation of B12-deﬁcient E. coli cells
E. coli OP50 was grown in M9 medium (3 g/L KH2PO4, 6 g/L
Na2HPO4, 0.5 g/L NaCl, 1 g/L NH4Cl, 1 mmol/L MgSO4, 50 μmol/L
CaCl2, 2 g/L glucose, and 4 mg/L thiamine hydrochloride) at 37
◦C
for 3 days. Cells were inoculated every 3 days into fresh M9 medium
and used as a food source for C. elegans. The B12 content (0.2 μg/g
wet weight) of E. coli cells grown in the M9mediumwas signiﬁcantly
reduced compared with cells grown in the standard Luria–Bertani
medium (11.1 μg/g wet weight).
2.3. Preparation of B12-deﬁcient C. elegans
C. elegans were grown at 20 ◦C on B12 (100 μg/L)-supplemented
medium using B12-deﬁcient E. coli OP50 as a food source. An individ-
ual worm egg was transferred onto each plate, which contained fresh
B12-deﬁcient medium seeded with the B12-deﬁcient E. coli OP50. Af-
ter the eggs hatched, worms were allowed to grow until they became
adults and had laid eggs (yielding the F1 generation). Individual eggs
were removed from the plate and each was transferred onto a fresh
plate containing B12-deﬁcient medium and grown to maturity under
the same conditions (yielding the F2 generation). This process was
repeated for ﬁve generations. After 3 days, adult worms of each gen-
eration (F1–F5) were used for experiments. This protocol is shown in
Fig. 1.
2.4. Vitamin B12 assay
F1–F5 worms grown under B12-supplemented or B12-deﬁcient
conditions were harvested and incubated for 1 h at 20 ◦C in fresh M9
medium to remove any residual E. coli cells. Worms (2 g wet weight)
were then disrupted using a hand homogenizer (AS ONE Corp., Osaka,
Japan) and sonicated (6 kHz for 60 s) three times. The worm ho-
mogenate was resuspended in 100 mL of 57 mmol/L sodium acetate
buffer (pH 4.8) containing 0.05% (w/v) KCN and boiled for 30 min.
The extract was centrifuged at 15,000 g for 15 min at 4 ◦C and the
supernatantwasused for assayingB12 concentrations by standardmi-
crobiological methods utilizing Lactobacillus delbrueckii subsp. lactis
ATCC 7830, as described previously [13].
2.5. B12-related biomarker assays
F1–F5 worms grown under B12-supplemented or B12-deﬁcient
conditions were collected and washed in M9 medium as described
above. The harvested worms were resuspended in 0.5 mL of 100mmol/L potassium phosphate buffer (pH 7.0) at 2 ◦C and homog-
enized using a hand homogenizer. The cell homogenate was cen-
trifuged at 15,000 g for 15 min at 4 ◦C and the supernatant was used
as a crude homogenate for subsequent biomarker assays.
Methylmalonic acid (MMA) and homocysteine (Hcy), two indices
of B12-deﬁciency, were assayed using the high performance liquid
chromatography (HPLC) methods of Al-Dirbashi et al. [14] and Febri-
ani et al. [15], respectively. MCM (methylmalonyl-CoA mutase)- [16]
and MS (methionine synthase)- [17,18] activities were assayed at 37
◦C as previously described. Total- and holo-enzyme activities were
determined in the presence or absence of each B12 coenzyme (Ado-
B12 for MCM and CH3-B12 for MS).
2.6. Analysis of egg-laying capacity, life cycle, and lifespan
Measurement of egg-laying capacity was based on the method
of Byerly et al. [19]. Individual L4-stage worms grown under B12-
supplemented or B12-deﬁcient conditions were selected, transferred
onto the fresh plates containing the same culture medium, and incu-
bated for 1 day at 20 ◦C. After laying eggs, each worm was removed
from the plate, and the eggs were counted. Egg counting was per-
formed in triplicate.
The life cycle and lifespan of B12-deﬁcient F5 worms were deter-
mined at 20 ◦C using the synchronization method of Johnson and
Wood [20]. Worms were scored as dead when they no longer re-
sponded to prodding with a pick. In each survival experiment, 100
worms were used.
























































Fig. 2. B12 content is reduced inworms grown under B12-supplemented and -deﬁcient
conditions. The B12 content of F1–F5 worms grown under control (black bar) and B12-
deﬁcient (white bars) conditions was assayed using microbiological methods. Data
represent the mean ± SD of 10 independent experiments. Different letters (a–e) indi-
cate values that are signiﬁcantly different (p < 0.01); identical letters indicate values
that are not signiﬁcantly different.
Fig. 3. Vitamin B12 deﬁciency changes the concentration of various B12-related
biomarkers. (A) Methylmalonic acid (MMA) and (B) homocysteine (Hcy) content, (C)
total- and (E) holo-methylmalonyl-CoA mutase (MCM) activity, and (D) total- and (F)
holo-methionine synthase (MS) activity were measured in extracts of worms grown
under B12-supplemented (black bar) and B12-deﬁcient conditions (white bars) for up
to ﬁve generations. For (E) holo-MCM and (F) holo-MS activities, measurements were
made in the absence of speciﬁc coenzymes. Data represent mean ± SD of 10 indepen-
dent experiments. Different letters (a–e) indicate values that are signiﬁcantly different
(p < 0.01); identical letters indicate values that are not signiﬁcantly different..7. Protein quantitation
Proteins were assayed by the method of Bradford [21] using oval-
umin as a standard.
.8. Statistical analysis
The effects of B12-deﬁciency on various C. elegans biomarkerswere
valuatedbyone-wayANOVA, and apost-hoc analysiswasperformed
sing Tukey’s multiple comparison tests. Analyses were performed
ithGraphPad Prism3 forWindows version 2.01 (GraphPad software
nc., La Jolla, CA, USA). All data are presented as the mean ± SD.
ifferences were considered statistically signiﬁcant when p < 0.01.
. Results and discussion
.1. Effects of B12-deﬁcient growth conditions on various B12-related
iomarkers in C. elegans
Nematodes grown on B12-supplemented M9 medium with B12-
eﬁcient E. coli OP50 as a food source (control) showed identical
rowth rates that were identical to that of worms grown under nor-
al conditions (data not shown), indicating that the experimental
ontrol conditions were adequate for the normal growth of C. ele-
ans. The control worms were able to ingest both B12-enriched agar
edium and B12-deﬁcient E. coli cells. Therefore, they would mainly
bsorb sufﬁcient amount of free B12 from the agar medium because
f low B12 content in E. coli.
Under B12-deﬁcient conditions, the B12 content of the worms de-
reased gradually over four generations (Fig. 2). TheB12 concentration
n F5 generation worms was only 4% compared with that in the con-
rol worms. These results indicate that dietary B12 deprivation over
ve generations leads to a signiﬁcantly decreased B12 status in C. el-
gans. The MMA and Hcy indices of B12 deﬁciency were assayed in C.
legans grown under both control and B12-deﬁcient conditions. There
as a signiﬁcant increase in the levels of both compounds between F3
nd F5 generation worms (Fig. 3A and B). Hcy and MMA levels were
pproximately four and ﬁve times greater, respectively, in F5 worms
rown under B12-deﬁcient conditions than in the control worms. Al-
houghholo-MCMactivity signiﬁcantly decreased in F4 and F5worms
rown under B12-deﬁcient conditions (Fig. 3E), the total MCM activ-
ty (holo- and apo-enzymes) increased (Fig. 3C), which indicates that
po-MCM activity is signiﬁcantly increased by B12 deﬁciency. Both
otal- and holo-MS activities signiﬁcantly decreased with each gen-
ration until the F4 generation and was maintained at a constant
evel thereafter (Fig. 3D and F). These results indicate that F5 genera-
ion worms grown under B12-deﬁcient conditions develop severe B12
eﬁciency. However, one day after transfer of B12-deﬁcient worms
nto the B12-supplemented medium, the level of these B12-related
iomarkers recovered considerably (data not shown). These results
ndicate that B12 functions as a cofactor for both MCM and MS in C.
legans and that B12-dependent changes in both MCM and MS en-
yme activities occur in C. elegans and mammals [22,23]. However,
sing the nematode model, the time needed to produce a severely
12-deﬁcient animal is only 15 days (i.e. ﬁve generations).
Holo-MS activity was rapidly decreased by F1 generation under
12-deﬁcient conditions (Fig. 3F), but holo-MCM activity was not
hanged until the F4 generation (Fig. 3E), which indicated that MS
s more sensitive to cellular B12 concentrations than MCM. Yamada
t al. have demonstrated that most MS activity is derived from holo-
nzyme in B12-sufﬁcient or -deﬁcient mammals because the apo-
nzyme is very unstable [22]. In contrast, Nakao et al. have indicated
hat holo-MCM activity was less than 5% of the total enzyme activity
n B12-sufﬁcient rats and that a marked increase in the apo-enzyme
ctivity occurred under B12-deﬁcient conditions [23]. In this C. elegans
tudy, holo-MCM activity was 97% of the total enzyme activity in thecontrol worms and holo-enzyme activity gradually decreased in the
F1 (92%), F2 (50%), and F3 (24%) generations, under B12-deﬁcient con-
ditions. However, the speciﬁc activity of holo-MCM did not change
until the F4 generation even if the B12 content of the worms signif-
icantly decreased along with increased MMA content. The details of
the occurrence of this MCM-independent increase in MMA concen-
tration soon after the onset of B12-deﬁciency remain to be elucidated.
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Fig. 4. Vitamin B12 deﬁciency reduces egg-laying capacity and lifespan, and increases
the lengthof the life cycle inC. elegans. (A) Total numberof eggsperworm, (B) the length
of the life cycle (h), and (C) the lifespan were determined in the control (black bar) and
B12-deﬁcient (white bars) F5 worms. Data represent mean ± SD of 10 independent
experiments. Different letters (a–d) indicate values that are signiﬁcantly different (p <
0.01); identical letters indicate values that are not signiﬁcantly different.3.2. B12 deﬁciency affects C. elegans egg-laying capacity, life cycle and
lifespan
Egg-laying rates signiﬁcantly decreased in B12-deﬁcient worms
(Fig. 4A), which also showed a signiﬁcantly prolonged life cycle com-
pared with the control worms (Fig. 4B). Similarly, B12-deﬁcient rats
have been reported to show severe growth retardation [24] and in-
fertility [25].
The lifespan of B12-deﬁcient F5 worms were signiﬁcantly de-
creased by B12 deﬁciency (Fig. 4C). The maximal lifespan of B12-
deﬁcient worms was reduced to 18 days, compared with a lifespan
of 24 days in the control worms (Fig. 4C). These data demonstrate for
the ﬁrst time that B12 deﬁciency signiﬁcantly reduces the lifespan of
animals.
B12 deﬁciency causes severe growth retardation and various
metabolic disorders in mammals [24]. The B12 coenzyme Ado-B12
functions as a coenzyme of MCM, catalyzing the isomerization of
R-methylmalonyl-CoA to succinyl-CoA in the mitochondria. Odd-
numbered fatty acids, branched chain amino acids, and cholesterols
aremetabolizedbymethylmalonyl-CoA to the tricarboxylic acid (TCA)
cycle intermediate succinyl-CoAbyMCM[1].WhenMCMactivitywas
signiﬁcantly decreased by B12 deﬁciency, MMA abnormally accumu-
lated in the cells [24]. The elevated concentration of MMA mainly
inhibits mitochondrial respiration because of competitive inhibition
of succinate dehydrogenase (EC 1.3.99.1) by MMA [25]. TCA cycle in-
hibition by MMA accumulation contributes to various metabolic dis-
orders associated with B12 deﬁciency [24], including severe growth
retardation (prolonged life cycle) in the B12-deﬁcient worms.
Many studies have demonstrated that there is a relationship be-
tween B12 deﬁciency and infertility in males and females [26,27].
However, the mechanism whereby B12 deﬁciency causes infertility
is poorly elucidated. CH3-B12 functions as a coenzyme of MS, which
catalyzes the methyl transfer from methyltetrahydrofolate to homo-
cysteine, resulting in the donation of amethyl group to homocysteine,
forming methionine [2]. MS is important to re-synthesize methion-
ine and tometabolizemethyltetrahydrofolate. Tetrahydrofolate is the
precursor for themethylene derivative of folate, which is essential for
thymidine supply and normal DNA replication in cells [28]. Further-
more, methionine is one of the amino acid building blocks of protein
and acts as the universalmethyl group donor (S-adenosylmethionine)
for a large number of methylation reactions. Yamada et al. [29] re-
ported that reduced testicular MS activity is the primary cause of
pathological impairment of spermatogenesis owing to B12 deﬁciency
and that methionine supplementation to the diet can reduce this
impairment. Bennet [30] has reported that B12 deﬁciency may lead
to recurrent fetal death owing to the elevated Hcy levels. The epi-
genetic regulation of gene expression involves remodeling of chro-
mation by either the addition of methyl group to DNA and/or the
post-translational modiﬁcation of histone amino acid residues. S-
adenosylmethionine is a critical substrate for histone methyltrans-
ferases, whereas S-adenosylhomocysteine is a potent inhibitor of
the enzymatic reaction [31]. It has been observed that the con-
centration of S-adenosylmethionine is reduced, with a concomitant
increase in S-adenosylhomocysteine concentration, in B12-deﬁcient
animal models or humans [32]. Our preliminary experiments in-
dicated that S-adenosylmethionine/S-adenosylhomocysteine ratios
signiﬁcantly decrease in B12-deﬁcient C. elegans relative to control
worms (data not shown). The decreased S-adenosylmethionine/S-
adenosylhomocysteine ratios may lead to abnormal epigenetic regu-
lation of gene expression, including gene relevant to fertility.
These observations suggest that decreased egg-laying and pro-
longed life cycle found in B12-deﬁcient worms are because of various
B12-associatedmetabolic disorders, which results in abnormal epige-
netic regulation of the expression of certain genes.
Approximately, 1% of B12-deﬁcient worms showed a speciﬁcmor-
phological abnormality (Fig. 5A), similar to the short and plump“dumpy” mutant phenotype that is formed because of disordered
cuticle collagen biosynthesis [33,34]. However, there is no informa-
tion available on the relationship betweenB12 deﬁciency and collagen
biosynthesis. Hcy, which is signiﬁcantly increased by B12 deﬁciency,
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Fig. 5. B12-deﬁcient C. elegans show morphological changes. Differential interference
microscopy images of the (1) control and (2) B12-deﬁcient worms were obtained using
an IX71 microscope (OLYMPUS Corp., Tokyo, Japan). The length of individual worms





























Ras been shown to interfere with post-translational modiﬁcations of
ollagen directly by inhibiting lysyl oxidase (EC 1.4.3.13), which is in-
olved in collagen cross-linking [35]. This observation andourdata in-
icate a possible link between B12 deﬁcient and collagen biosynthesis
ncluding post-translational modiﬁcations of collagen cross-linking.
Our results indicate that B12 is essential for C. elegans growth and
hat prolonged B12 deﬁciency induces a number of phenotypes, in-
luding decreased egg-laying capacity (infertility), prolonged life cy-
le (growth retardation), and a reduced lifespan. Therefore, we pro-
ose that C. elegans is an ideal model organism for investigating the
echanisms driving such B12-deﬁcient phenotypes, as B12 deﬁciency
an be induced in this animal in only 15 days. However, there are
ome limitations to this animal model; for example, C. elegans does
ot have any blood corpuscle systems. Moreover, bioinformatic anal-
ses indicate that C. elegans also does not have any orthologs of three
12-transport proteins (haptocorrin, intrinsic factor, and transcobal-
min II) involved in human gastrointestinal absorption and subse-
uent blood circulation of B12. Thus, C. elegans is not suitable for use
s a model organism to study the mechanisms of some human B12-
eﬁcient disease phenotypes, such as megaloblastic anemia and dys-
unctions of intestinal absorption and transport of B12. However, this
nimal is widely used as a model organism for studying the mecha-
isms of fertilization [36] and embryonic cell division [37]. Moreover,
. elegans is often used for understanding human brain and neuronal
isorders [38] in addition to the effects of certain molecules on learn-
ng andmemory [39]. C. elegansmay become a suitable organism and
powerful new tool for the study of B12-deﬁcient human diseases
uch as infertility [26,27,29], fetal death [30,40], neuropathy [41],
nd cognitive impairment [42].
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